I-KID: Infant KIdney Dialysis and filtration: evaluation of efficacy, outcomes and safety of a new infant haemodialysis and ultrafiltration machine in clinical use

The Newcastle Upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 97 人开始时间: 2018年6月28日最近更新: 2024年1月29日

试验速览

2023 Results article in https://dx.doi.org/10.1097/PCC.0000000000003220 (added 13/03/2023) 2021 Protocol article in https://doi.org/10.1136/bmjpo-2021-001224 (added 19/01/2024) 2024 Results article in https://doi.org/10.3310/VGJT3714 (added 19/01/2024)

•Current inclusion criteria as of 25/09/2019:
•1. Patients in PICU with a body weight of 0.8-7.99 kg who require continuous RRT for acute renal insufficiency or fluid overload as part of their standard clinical care
•2. Person with legal parental responsibility (PR) for the patient has provides written informed consent for the patient to take part in the study. This may be after the patient has started dialysis in an emergency situation to not delay any treatment.
•Previous inclusion criteria:
•1. Patients in PICU with a body weight of 0.8 kg – 7.99 kg who require continuous RRT for acute renal insufficiency or fluid overload as part of their standard clinical care
•2. Person with legal parental responsibility (PR) for the patient has provided written informed consent for the patient to take part in the study

•1. Patient with known chronic renal failure already on adequate RRT
•2. Patient already established on adequate RRT for whom entry into the study would require additional central venous access, if that access is not clinically indicated
•3. Patient has an underlying metabolic diagnosis, including hyper ammonaemia
•4. Clinician makes a clinical decision that the patient should not receive RRT using NIDUS
•5. Unable to receive written informed consent for data collection from a person with legal PR for the patient

发起方